6 Since then, states have altered their positions on covering anti-obesity GLP-1 therapies: Four have withdrawn coverage entirely (California, New Hampshire, Pennsylvania, and South Carolina), three have added coverage (Missouri, Tennessee, and Utah), and at least two states (Michigan and Virginia) have enacted more narrow utilization criteria, limiting future use to those with morbid obesity
How the Model Works Typical process: Patient completes online consultation Provider evaluates eligibility Prescription written if appropriate Prescription sent to partner pharmacy Pharmacy compounds and ships medication Ongoing follow-up with provider Provider responsibilities: Evaluate patient appropriateness Write valid prescriptions Select reputable pharmacy partners Provide ongoing medical supervision Pharmacy responsibilities: Fill prescriptions according to standards Ensure quality of compounded products Ship properly Maintain proper storage Evaluating a Telehealth Providers Pharmacy Partners Questions for telehealth providers: Which pharmacy compounds your semaglutide
Where Consumers Can Start an altRx GLP-1 Eligibility Evaluation Because GLP-1 medications are prescription products, this is not a standard product purchase
Week 21+: Discontinuation
UNICEF DATA
While some studies have shown that chromium supplementation can reduce A1C levels in people with type 2 diabetes, it showed no effect on fasting blood glucose or lipid levels
